TTR and cardiac amyloidosis: In another study comparing 96 patients with cardiac amyloidosis (AL, wild-type TTR, and mutant TTR amyloidosis) and 91 patients with non-amyloid causes of cardiac hypertrophy, hs-TnT levels were significantly higher in the cardiac amyloidosis group than in the other hypertrophy group [113].